Peptron (XKRX:087010) Short-Term Debt : ₩4,549 Mil (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Peptron Short-Term Debt?

Peptron's Short-Term Debt for the quarter that ended in Mar. 2024 was ₩4,549 Mil.

Peptron's quarterly Short-Term Debt declined from Sep. 2023 (₩9,049 Mil) to Dec. 2023 (₩4,549 Mil) but then stayed the same from Dec. 2023 (₩4,549 Mil) to Mar. 2024 (₩4,549 Mil).

Peptron's annual Short-Term Debt increased from Dec. 2021 (₩3,000 Mil) to Dec. 2022 (₩9,049 Mil) but then declined from Dec. 2022 (₩9,049 Mil) to Dec. 2023 (₩4,549 Mil).

Peptron Short-Term Debt Historical Data

The historical data trend for Peptron's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Peptron Short-Term Debt Chart

Peptron Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

Get a 7-Day Free Trial

3,000.00

9,049.00

4,549.00

Peptron Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Debt	Get a 7-Day Free Trial															9,049.00	9,049.00	9,049.00	4,549.00	4,549.00

Peptron Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Peptron Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Peptron's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Peptron (XKRX:087010) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Peptron Inc (XKRX:087010) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

37-24, Yuseong-daero 1628 beon-gil, Yuseong-gu, Daejeon, KOR, 305811

Website

http://www.peptron.com

Peptron Inc is a biotechnology company engaged in developing fundamental technologies for peptide-based medicines. Its technology includes PeptrEX and SmartDepot. PeptrEX is an automatic system, enabling to synthesize simultaneously from a few to hundred types of peptides. SmartDepot is a proprietary ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of the drug. The group's research and development products include Luphere Depot for the treatment of prostate cancer and endometriosis, SR Exenatide PT302 AND SR EXENATIDE PT304 for the treatment of type II diabetes, SR Exenatide PT320 and 330 for the treatment of Parkinson's and Alzheimer's disease and SR Octreotide for the treatment of acromegaly and carcinoid tumor.

Peptron (XKRX:087010) Headlines

No Headlines